Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists with tools to visualize tumors in real-time during surgery with the goal of improving cancer surgery outcomes. The CF800 liposomal imaging agent accumulates specifically at the tumor boundary with healthy tissue and enables the precise visualization of multiple solid tumor types using existing operating room equipment with CT and near-infrared spectrum imaging capabilities.

Event details

Date: October 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total